GlaxoSmithKline finance boss banned from leaving China
Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.
The travel ban was imposed on Steve Nechelput at the end of June, said a company spokesperson.
On Monday, police in China said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to facilitate bribes to doctors.
GSK has said it is deeply "concerned and disappointed" by the allegations.
Martin Patience reports from Beijing.
18 Jul 2013
- From the section Business